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Available online 17 January 2015Background: Relapse prevention interventions for Bipolar Disorder are effective but implemen-
tation in routine clinical services is poor. Web-based approaches offer a way to offer easily
accessible access to evidence based interventions at low cost, and have been shown to be effective
for other mood disorders.
Methods/design: This protocol describes the development and feasibility testing of the ERPonline
web-based intervention using a single blind randomised controlled trial. Data will include the
extent towhich the sitewas used, detailed feedback fromusers about their experiences of the site,
reported benefits and costs to mental health and wellbeing of users, and costs and savings to
health services. We will gain an estimate of the likely effect size of ERPonline on a range of
important outcomes including mood, functioning, quality of life and recovery. We will explore
potential mechanisms of change, giving us a greater understanding of the underlying processes of
change, and consequently how the site could be made more effective. We will be able to
determine rates of recruitment and retention, and identifywhat factors could improve these rates.
Discussion: The findingswill be used to improve the site in accordancewith user needs, and inform
the design of a large scale evaluation of the clinical and cost effectiveness of ERPonline. They will
further contribute to the growing evidence base for web-based interventions designed to support
people with mental health problems.
©2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
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Relapse prevention interventions for Bipolar Disorder (BD)
involve supporting people to identify triggers and earlywarning
signs (EWS) of relapse, and learn effective coping strategies toental Health Research,
2.
.
. This is an open access article unmanage mood [1]. Evidence shows that this kind of approach
may reduce relapse rates, hospitalisations, and improve func-
tioning and quality of life when offered alongside medication
[2,3]. Consequently, this kind of approach is recommended as an
adjunct to medication by international clinical guidelines.
Enhanced Relapse Prevention (ERP) [4] builds directly on
the work of Perry et al. [2] but develops this approach by:
(1) strengthening the coping strategies for depression (for
which the Perry study showed no specific impact) in an attemptder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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a relative where appropriate; and (3) adapting the format to be
delivered by frontline care staff in routine clinical services to
aid implementation. However, many people with bipolar
disorder do not have regular access to care staff able to offer
this kind of intervention. To address this problem, we have
developed aweb-based version of the ERP intervention and here
we outline a protocol to test the acceptability and feasibility of
this approach.
Computer-based interventions, including web-based pack-
ages, are recommended to increase access to psychosocial
interventions in mental health [5]. In treating depression and
anxiety, computerised interventions have already been shown
to be clinically and cost-effective, acceptable to service users,
and highly accessed [6–10]. More research is needed to test the
effectiveness of computer-based interventions for people with
severe mood disorders including Bipolar Disorder.
To date, we have identified seven online interventions for
Bipolar reported in the literature [11–17]. Whilst all support
the internet as an acceptable mode of delivering treatment to
this population, only 3 [11–13] have provided outcome data.
Beating Bipolar was found to improve psychological quality of
life, in post hoc analyses, but no other effects were found on
overall quality of life, functioning, symptoms, or relapse [11].
Living with Bipolar [12] significantly improved quality of life,
well-being and recovery compared to treatment as usual. In
Australia, the Online Bipolar Education Program (BEP) [13] did
not improve outcomes compared to an information control
condition [18].
Taken together, these findings suggest a considerable
amount of interest in the development of web-based interven-
tions for BD, evidence that they are acceptable to service users
and indications that this may be an effective way to increase
access to evidence-based interventions. However, many ques-
tions regarding content, style of delivery, required support, and
mechanism of action remain unanswered, suggesting a need
for further research in this area.1.1. Aims
The main aims of the study are to:
1. Assess the feasibility of (i) creating a web-based version
of Enhanced Relapse Prevention for Bipolar Disorder and
(ii) an RCT design using web-based and telephone data
collection to evaluate effectiveness.
2. Determine the acceptability of ERPonline for people with BD
via (i) amount of use of the ERPonline website (e.g. statistics
per user, per module, per re-visit), (ii) number and type
of adverse events associated with use of the site, and
(iii) detailed feedback from participants about their experi-
ences of this intervention which can be used to inform
future developments. This will include feedback from those
in the intervention armwho did not engage with ERPonline,
where possible.
3. Determine the feasibility and acceptability of data collection
via the internet and telephone as measured by rates of
recruitment, retention, data completion, and direct feedback
from participants including a feedback survey on taking part
for the control arm, and qualitative interviews with those inthe intervention arm. This will include participants who
dropped out of the study, where possible.
4. Estimate the likely effect size of the intervention on a range
of outcomes, particularly noting any negative impacts.
5. Explore mechanisms of change on outcome measures to
understand processes underlying the impact of the
intervention.
For a large scale definitive trial to be feasible will require us
to have produced an ERPonline website which functions as
designed and which can be adapted to accommodate any key
limitations identified in feedback from participants. We will
have designed a strategy for the recruitment and retention of
participants. We have chosen not to specify arbitrary criteria to
decide if the rates achieved make a large scale trial feasible,
because this depends on the level of precision required by
funding bodies. However data from this trial will allow us to
make reliable estimates of the rates of recruitment, rates of
retention, level of use of the site, and effect size of the
intervention across a number of outcome variables. This data
will allow us to calculate sample sizes required for a large scale
definitive trial of the clinical and cost effectiveness of
ERPonline, across a range of precision estimates.
2. Methods
2.1. Design
A single blind RCT, with nested qualitative design, will
compare individuals receiving access to the ERPonline website
for 12 months alongside their usual treatment to a ‘waitlist
control’ arm who will receive usual treatment only for the
12 months of the study but will then have access to the
ERPonline website.
2.2. ERPonline intervention
The evidence-based Enhanced Relapse Prevention (ERP)
manual, previously developed by members of our research
team [4], has been adapted and translated into a free-to-access,
web-based, self-management resource. ERPonline focuses on
the acquisition of skills to prevent future relapse, which has
already been shown to be effective when delivered face to face
[19]. The adaptations for the web-based version of ERP were
informed by a review of the relevant literature, and stated
preferences of service users [20]. For example, ERPonline
allows the user to access relevant sections, when required,
based on individual needs (rather than in a staged sequential
way) andwill be available in anopen and free-to-access format.
The option to involve a supporter (a relative or health
professional) has been retained as this was identified as
beneficial in the delivery of face-to-face ERP by service users,
Care Coordinators, and relatives [21].
In order to ensure that ERPonline is engaging and has high
face validity, development of the site has featured an iterative
cycle of clinical input, service user review of content and
usability, and web-based prototyping. The Service User Refer-
ence Group (SURG) formed for this process will continue to
inform the ERPonline trial including recruitment, retention,
and dissemination of findings. Where possible, the site is
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guidelines [22].
ERPonline is not intended to replace current treatment
where this is appropriate and available, but may increase
choice and access by allowing individuals who do not currently
have access to evidence-based psychological input to access
helpful support.
The key modules in ERPonline are summarised in Table 1.
There is a logical order to the modules, though the
participants are free to browse through them as they please.
Each module includes an introductory video from amember of
the research team outlining the aim of the module and the
tasks within it. This information is also provided in the text
which is deliberately arranged in short paragraphs providing
only essential information with links to information dialog
boxes which provide expanded information on key points. This
allows the user to control the level of detail they receive. Case
examples provided by the SURG are included to convey real
lived experience illustrations of the problems identified and
strategies to overcome them.
The introductory section includes information about what
ERPonline is, who it is for, why someone might want to use
ERPonline, how to involve a supporter, and how to use the site.
The intervention section then includes the key modules
outlined in Table 1, with a brief description of what is covered
in each. In each module, the participants are asked to enter
relevant personal information, which is collated in the final
module to form a “Staying Well Plan”. This individualised plan
includes (1) key things tomanagemy stress; (2) things I can do to
keep my social rhythms regular; (3) triggers for high moods and
how to manage them; (4) triggers for low moods and how to
manage them; (5) early warning signs and coping strategies for
high mood; and (6) early warning signs and coping strategies for
low mood. The participants are encouraged to review this plan
on a regular basis, especially following any relapses that do
occur.
The final section provides additional support, including
links to other statutory and non-statutory care providers, and
access to technical support with the website. A user discussion
forum was originally intended, but this proved too difficult toTable 1
Key intervention modules in ERPonline.
Getting started How to use the site Ways to naviga
What is Bipolar? Background inf
consequences,
Key modules Mood charting How to use an o
ﬂuctuation and
Life charting Complete a cha
strategies for fu
Identifying triggers Detailed analys
how to manage
Speciﬁc moods Early warning signs (EWS) — high mood Detailed analys
Coping strategies — high mood Review of curre
may be helpful
Early warning signs (EWS) — low mood Detailed analys
Coping strategies — low mood Review of curre
may be helpful
Wrapping things up Staying well strategies Identifying and
Understanding
How relationsh
Your staying well plan An individualis
and coping stramanage within the resources available. Moreover, the partic-
ipants in the trial of a web-based depression intervention,
Beating Bipolar [23], reported that there was a tendency for the
forum to be dominated by a few strong characters who would
sometimes not listen to or accept other peoples' point of view,
causing distress among some individuals. Instead, ERPonline
includes a Frequently Asked Questions (FAQ) function that is
asynchronous, with questions submitted via an online form
going straight to unblinded members of the multidisciplinary
research team.
Throughout the site, users are encouraged to involve a
supporter (close friend or relative) where they wish. The
introductory section includes a rationale for why this might
be helpful, and guides the participants to think through who
they might like to invite to be their supporter. Highlighted
advantages of involving a supporter include emotional and
practical support, recognition of subtle changes in mood and
behaviour, and facilitating implementation of coping strategies
developed during ERPonline. Some of the potential disadvan-
tages identified include not wanting to burden others with
these tasks, sense of loss of autonomy, and notwanting to share
personal details which may be relevant to understanding
relapse. The ERPonline site emphasises that it is not necessary
to involve a supporter.
The intervention website uses Drupal, the PHP open source
content management system, with custom Drupal modules
built to deliver the interactive portions of the site. One of these
custom modules handles the collection of web traffic data
into the site database. This system sits on top of the MySQL
open source database. Drupal is an intensely supported and
developed projectwith security teamswhowork to ensure that
security threats are dealt with proactively. The hardware on
which the site runs is in a UK-based custom built data centre
providing physical security, natural disaster protection, data
redundancy and generator backed uninterruptible power
supply.
The ERPonline intervention is being compared with treat-
ment as usual (waitlist control group) to assess its feasibility,
acceptability and potential impact on key outcomes. The trial is
being conducted by a multidisciplinary team of academics,te the site to get the best from the available modules
ormation about what Bipolar Disorder is, theories about causes, common
and an overview of available treatments
nline tool to monitor mood on a daily basis to help recognise normal mood
pick up early signs of a mood episode
rt of past mood episodes, identifying potential triggers and coping
ture mood changes
is of triggers of previous mood episodes, followed by a personalised plan of
triggers
is of EWS of high mood to develop a relapse signature for (hypo)mania.
nt strategies to manage high mood and introduction to new strategies that
is of EWS of high mood to develop a relapse signature for depression
nt strategies to manage low mood and introduction to new strategies that
managing stress levels
the importance of social rhythms and how to regulate these to managemood
ips with other people impact on mood
ed summary of staying well strategies, early warning signs to look out for,
tegies to regulate mood
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bipolar disorder, based at Lancaster University, the University
of Nottingham, and Cumbria Partnership NHS Foundation Trust
in the North West of England. The trial is supported by an
independent Steering Committee.
2.3. Sample size & participants
We aim to recruit 125 participants in total which, allowing
for a conservative attrition rate of up to 35%, will provide a final
sample of n=40per armof the trial. The conservative estimate
of attrition was based on a wide range of retention rates across
previous trials of web-based interventions for BD, including
17% attrition for Living With Bipolar [24], 26% attrition for
Beating Bipolar [25], and 46% attrition from randomisation for
BEP [26]. This sample size is sufficient for the aims of the study
including assessing feasibility of recruitment and retention
strategies, and acceptability. Consistent with MRC complex
interventions framework [27], this study is not powered to
find a statistically significant difference on any one primary
outcome. The trialwill allow us to estimate the effect size of the
impact of ERPonline on a range of outcome measures, but a
large scale definitive trial, informed by the findings of this
study, will be needed to test the clinical and cost effectiveness
of ERPonline.
Inclusion criteria: (i) aged over 18 years of age; (ii) access to
a telephone, computer and the internet; (iii) meet research
diagnostic criteria for a diagnosis of bipolar disorder type 1 or 2;
(iv) the ability to understand spoken and written English; and
(v) have had at least 3 relapses in their lifetime, with 1 falling in
the preceding 2 years. This is to ensure that we have a sample
considered high risk for relapse, for who this kind of
intervention is most appropriate.
Exclusion criteria: (i) in current episode (within previous
4 weeks) — this is because the intervention focuses on the
identification and management of early warning signs of
relapse and therefore is not intended for those currently in
episode who would benefit from a different kind of approach;
(ii) currently taking part in another intervention study (or
follow-up period); and (iii) currently being treated under a
section of the Mental Health Act or unable to give informed
consent. Individualswho register an interest butwho are either
currently in episode and/or being treated under the Mental
Health Act will be regularly contacted to reassess eligibility and
invited to take part when they meet criteria. If this does not
occur within the study period, they will be offered access to
ERPonline at the end of the study.
2.4. Procedure
Progression through the study is outlined in Fig. 1.
2.5. Recruitment
Referrals are sought from participating NHS Trusts in the
UK, with support from the Mental Health Research Network, a
publicly funded national workforce to aid the recruitment of
participants to nationally funded research studies. The partic-
ipants from across the UKwill also be able to self-refer, andwill
be recruited via newsletters sent to existing service user
networks (e.g., voluntary sector websites, mental health webforums), social media (e.g, Twitter and Facebook), and in
posters displayed in public areas (e.g., libraries, community
centres), in NHS services, and in the offices of voluntary sector
organisations. Recruitment materials ask potential participants
to visit the study website (www.erponline.co.uk) where they
can access information about the study, contact details of the
research team, an eligibility checklist, and can register their
interest in taking part. To facilitate recruitment, registration
will be available during the setup phase of the study for
2 months before the trial starts. Registered individuals will be
sent regular email updates to encourage continued interest.
Once the trial starts, eligible participants will be sent a link via
email to an online consent form. Consent is taken online but
requires the participants to indicate that they have read and
understood the online Participant Information Sheet. They are
encouraged to print out the PIS, discuss the content with
friends and family, and contact the research team by telephone
or email with any queries. Following online consent they are
contacted by telephone to arrange a convenient time to
complete the first screening interview to confirm diagnosis
and assess relapse history. Verbal consent is reassessed at this
point.
2.6. Screening, assessments, randomisation and blinding
The Structured Clinical Interview for theDSM-IV (SCID) [28]
will be used to confirm a diagnosis of bipolar disorder and
assess thenumber of previous mood episodes. This will be
administered via telephone by a trained researcher. Good
reliability between telephone and face-to-face interviews has
been found for diagnosing a variety of affective disorders
[29,30]. All SCID interviews are followed by a telephone call
within 48 hours to inform the participant whether or not
they are eligible for the study, and to check for any adverse
consequences from the telephone SCID. People who are not
eligible are directed to information about other relevant
research opportunities. Thosewho are not eligible only because
they are currently in a mood episode, will be monitored on a
regular basis so they can come into the trial at the appropriate
time. Those who are eligible for the study will then complete
the baseline assessment measures (listed below). Interviewer
rated measures are conducted by trained researchers over the
telephone. Self-reportmeasures are completed online via a link
sent by email.
After baseline assessment, random allocation to the inter-
vention or waitlist control arm will be conducted by an
independent unit based at the Christie NHS Foundation Trust,
Manchester. The 1:1 individual randomisation between the
two arms is minimised on the number of previous episodes
banded as (b8, 8–20, 20+), and includes a random element.
Allocation of each participant is given to the trial manager by
telephone. The participants are informed by telephone or
email. The trial manager will also inform the Care Coordinator
and/or GP that the participant is taking part in the study and
which arm they have been randomised to. Minimisation was
chosen in preference to stratification because of the small
sample size and a random element was included to minimise
predictability of allocation. The researchers carrying out the
follow-up assessments will remain blind to the study arm of all
the participants throughout the trial period. To maximise
blindness, blind researchers are housed in a separate office and
Fig. 1. E-consort for ERPonline.
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randomisation information. Prior to all follow-up assessments,
participants will be reminded by the trial manager not to
disclosewhich armof the trial theywere allocated to or provide
any information that may indicate this. This is reiterated by
the interviewer at the start of all follow-up interviews. Any
instances of un-blinding will be recorded and reasons noted.
Following randomisation, the participants in the ERPonline
arm will be provided with a username and password (whichthey can reset for personal preference) via email to access
the intervention website. The participants can then access
ERPonline as often as they would like from a location of their
choice for 12 months. Reminder emails encouraging partici-
pants to visit the site will be sent every 4–8 weeks during the
trial. The research team can be contacted with queries via the
FAQ link or Technical Support link. These links will not involve
any contact with the researcher responsible for blind follow-up
assessments.
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48 weeks post-randomisation. At 0, 24 and 48 week assess-
ments, interviewer ratedmeasures are conducted by telephone,
and online self-report measures are also completed. At 12 and
36 week assessments, only interviewer rated assessments by
telephone are carried out. To encourage retention during the
follow-up period, participants will be contacted by telephone
and/or email to confirm the scheduled date and time date for
each follow-up interview and to answer any queries that they
may have 2 weeks prior to the date their next interview is due.
In acknowledgement of their contribution to the study, the
participants also receive £10 in vouchers at each assessment
point.
2.7. Measures
2.7.1. Baseline and outcome measures
2.7.1.1. Interviewer-rated outcome measures (administered at
baseline, 12, 24, 36 and 48 weeks)
Structured Clinical Interview for DSM-IV Longitudinal Interval
Follow-up Examination (SCID-LIFE) [31]. The SCID-LIFE will be
delivered via telephone to generateweekly scores ofmania and
depression on a 1–6 severity scale. The SCID-LIFE includes
items from the SCID as well as the Hamilton Depression Rating
Scale (HDRS) [32] and Mania Rating Scale (MRS) [33]. The
SCID-LIFE is reliable for use in BD [34]. Scores of 5/6 indicate
the presence of symptoms and impact on functioning that
corresponds to criteria for major mood episode as defined by
theDSM-IV.Weekly scoreswill be used to examine the number
of weeks out of episode (4 or less on SCID LIFE), number of
weeks without impairment (2 or less on SCID LIFE) and time to
first episode of depression and mania.
Personal & Social Performance Scale (PSP) [35]. The PSP is an
interview schedule to assess functioning in the domains of
socially useful activities, personal and social relationships, self-
care, and disturbing and aggressive behaviours. It has been
used previously to assess outcome in response to treatment for
BD [36].
Multidimensional Scale of Independent Functioning (MSIF) [37].
The MSIF will assess functioning in terms of role responsibility,
presence and level of support, and performance quality in
relation to work, education, and living. The MSIF is a valid and
reliable indicator of functioning and has been used as an
outcome measure in relation to treatment for BD [38].
2.7.1.2. Self-report outcomemeasures (baseline, 24 and 48 weeks)
Work & Social Adjustment Scale (WSAS) [39].WSAS is a brief 5-
item measure of functioning in the domains of work, home
management, social leisure, private leisure, and relationships. It
has been extensively used in longitudinal research on BD
[40,41], including trials of web-based therapy [42]. This will be
used to estimate self-reported impact of ERPonline on
functioning.
Quality Of Life in Bipolar Disorder Scale (QoL.BD) [43]. The
QoL.BDwas developed specifically to assess quality of life in BD
within several areas including physical, sleep, mood, leisure,spirituality, and identity. A rating scale from 1 = ‘strongly
disagree’ to 5 = ‘strongly agree’ is used to describe to what
extent the participants have experienced a range of items over
the past week (e.g., ‘Kept a routine in my sleep-wake cycle’).
Questions relating towork (including voluntary) and education
are only answered if applicable. This will be used to estimate
impact of ERPonline on quality of life and has been shown to be
sensitive to change in previous studies of interventions for BD
[24].
Bipolar Recovery Questionnaire (BRQ) [44]. The BRQ consists of
36 items developed specifically to measure personal recov-
ery in BD (e.g., ‘I am able to engage in a range of activities
that are valuable to wider society’). The participants mark
to what extent each statement describes their mental health
and recovery over the past week on a visual analogue scale
anchored ‘Strongly disagree’ and ‘Strongly agree’. The BRQ
has been shown to be sensitive to change in previous studies
evaluating interventions for BD [12,45].
Current Treatment Questionnaire. This measure was developed
by the research team for this study, and will record treatment
actually received by participants (other than ERPonline). This
will allow a definition of current treatment to which ERPonline
will be compared, and to explore current accessibility to
evidence-based psychological interventions.
EQ5D5L [46]. This is a widely used brief self-report measure
with 5 scales (mobility, self-care, usual activities, pain/
discomfort and anxiety/depression) each rated on 5 levels (no
problem, slight, moderate, severe, extreme). There is good
evidence that this measure reflects the impact of a wide range
of physical and mental health problems including anxiety and
depression [47]. Themeasure has beenused in previous trials of
interventions for people with bipolar disorder [48]. However,
pilot use of the measure in this study would further assess
the feasibility of using the measure online, with a population
recruited via a wider range of methods than previous trials
including online forums and media, and would allow us to test
whether it is sensitive to change in this format.
Client Socio-Demographic and Service Receipt Inventory —
European version (CSRI; [49]). CSRI will collect data to allow
calculation of the direct costs and savings of offering and
supporting ERPonline in the intervention arm, and indirect
costs/savings in both arms. Indirect costs will include health
and social care contacts, medications prescribed, and time off
work. The feasibility of collecting this data in self-report form
will be assessed. The participants will be asked to identify
any other substantial changes that are not captured by the
pro-forma.
2.7.1.3. Self-report process measures (baseline, 24 and 48 weeks)
Early warning signs checklists for relapse (EWS depression and
EWS mania; [50]). These are 32-item and 31-item checklists
assessing the frequency of monitoring of EWS and then timing
of common early warning signs in relation to onset of
depression and mania, respectively. Initially respondents are
asked to indicate how frequently they monitor EWS and to
spontaneously generate the signs they monitor. They then
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whether it is absent altogether, an early sign, a late sign, or
comes during full relapse. The full measure is used at baseline
but only the item assessing frequency ofmonitoring is included
in the follow-up assessments to assess the impact of ERPonline
on monitoring impact, whilst reducing the participant burden
of measures.
Brief Illness Perception Questionnaire (BIPQ; [51]). This measures
11 beliefs about mood swings (e.g., ‘Do you think you are to
blame for your mood swings?’) on a Likert scale from 0 to 10
where 0 indicates an absence of that belief and 10 indicates a
strong conviction in that belief. The BIPQ is associated with
time to relapse and depression in BD [51] and will be used to
explore the mechanism of change in this study.
Medication Adherence Rating Scale [52]. This measure has 10
yes/no items relating to behaviours and attitudes towards
medication over a week long period (e.g., ‘Are you careless at
times about taking your medication?’). This scale will be used
to determine the impact of medication adherence as a
mechanism of change in this study.
2.7.1.4. ERPonline feedback
A brief questionnaire was developed to obtain written
feedback about the ERP intervention from all users at 24 and
48 week follow-up. This is a combination of free text boxes,
rating scales, and multiple choice questions, asking for general
feedback on ERPonline (e.g. how satisfactory they found it, what
was/was not useful), questions about relevance and helpfulness
of specific modules, and practical issues about internet use and
access. Qualitative interviews will be used to explore peoples'
experiences of participating in the trial and using ERP-online. A
sample (n = approx 20) will be purposively selected from the
treatment group to ensure appropriate gender and age distribu-
tion and different patterns of website use. The sample will be
invited to take part in topic guided telephone interviews lasting
45–60 min. Topics will include: perceptions of impact/outcome
of the intervention, factors shaping usage of the resource,
attitude towards the online format, and experience of partici-
pating in research. Interviews will be digitally recorded and
transcribed. People in thewaitlist control groupwill be invited to
provide feedback on their experience of taking part in the study
using an open-ended online-survey.
2.8. Dropout from the study
The participants who wish to cease participation in the
project will be invited to complete a form stating their
reason for dropping out, or to provide information so that a
member of the research team can complete this on their
behalf. Understanding the reasons for dropout is essential
information both to guide the design of future definitive
trials with a view to minimising dropout, and to enable the
analysis protocol to handle incomplete follow-up data
appropriately. Depending on the participant preference,
this form will either be completed with the participant by a
researcher over the telephone, or the participant can opt to
complete an online self-report questionnaire. The partici-
pants will be asked at this point whether they still consent tobe contacted about taking part in a qualitative interview,
which will further explore reasons for dropout.
2.9. Dealing with risk
There are several potential riskswhichneed to be addressed
in this study.
It is possible that researchers are made aware of risk to the
participants or others, at any point during the study. At initial
consent the participants will be required to provide contact
details for their Care Coordinator and/or GP. It will be made
clear that although information collected during the study will
remain confidential, if there are any risk issues then informa-
tion will be shared with existing care teams. If an urgent risk is
identified, the researcher will attempt to ensure the immediate
safety of the participant and other individuals by informing the
care team/GP/emergency services as appropriate.
Conducting the SCID-LIFE interview over the telephone is a
relatively new and potentially efficient way to collect data.
However, the impact of this on participants is not yet fully
understood. Following each telephone interview, all partici-
pantswill be offered a ‘support call’ 24–48 hours later to assess
any adverse impact of the assessment process. A log will be
kept of any reported impacts. Supervision is provided to the
researchers by a qualified Clinical Psychologist.
The intervention site invites users to submit queries to a
multidisciplinary team of clinicians, academics, and service
users. The team replies directly to the individual submitting the
question and the question and answer can then be considered
for the Frequently Asked Questions page. However, it is made
clear that the research team cannot respond to individual
urgent clinical need, which should be directed to existing care
teams. The intervention website also includes a list of national
organisations that can be contacted for further information and
support including Mind, ReThink, Bipolar UK, the NHS and
Samaritans.
2.10. Analysis
A key focus of this trial is on issues of feasibility and
acceptability, therefore much of the outcome data will be
descriptive statistics summarising rates of recruitment, demo-
graphics of recruited sample, pattern and frequency of website
use, retention to follow-up assessments, andqualitative feedback
from participants about their experiences of the intervention.
Quantitative outcome data will be examined to inform
the selection of measures sensitive to change, and to identify
potential positive and negative impacts that should be further
tested in a large scale definitive trial. This study is not powered
to test for a statistically significant impact. As such, we neither
specify a primary outcome, nor set a level of statistical
significance for interpreting analyses.
To assess the impact of ERPonline on each of the repeated
outcomemeasures we will analyse the data using linear mixed
models, which allow for correlation between repeated mea-
sures from the same participant. We will compare the results
from unadjusted analyses, which include the treatment effect
as the only covariate, and analyses that adjust for baseline
variables. These analyses will inform the details of any future
trial design by providing estimates of likely effect sizes,
variability of outcome within treatment groups and any
substantial main effects of baseline variables and/or their
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suggest that a stratified design will be more efficient than a
simple randomisation. Incomplete records from patients who
drop out of the study will be retained. The analyses will use
maximum likelihood estimation for all model parameters. This
ensures validity under the assumption that dropouts are
missing at random in the sense of Rubin (1976)[53]. The
implied estimand for any effect is then the effect that would be
experienced in the absence of dropout. To analyse time to first
relapse wewill use a competing risks Cox proportional hazards
regression model with subject-level frailty and stratified by
type of relapse (depressive or hypomanic/manic/mixed epi-
sodes). We will explore potential mechanisms of change by
analysing the ability of process measures to predict change in
outcomemeasures over time, using multivariate hierarchically
structured linear models. Process measures include beliefs
about mood swings, frequency of early signs monitoring, and
medication adherence. Finally, direct and indirect costs in both
arms of the trial will be described, along with an assessment of
the suitability of the measures for a large trial.
All analyses will use the R open-source computing environ-
ment. R code will be lodged in an open-access repository to
ensure reproducibility of results.
Qualitative data from the feedback survey will be
summarised into key themes. Transcripts from the in-depth
interviews will be analysed thematically, which involves
coding of data, identification of thematic headings, and then
extraction of data. Patterns and connections across the themes
will be explored. The analysis will be validated by cross-
checking of independent coding and transcript extraction by
another member of the research team. The analysis team will
include a service user and as the analysis progresses a consult
with the ServiceUser ReferenceGroupwill be used to check the
team's interpretations and ensure that this perspective is
brought to the analysis.3. Discussion
Consistent with the MRC framework for development of
complex interventions [27], this study aims to develop and test
the feasibility and acceptability of the ERPonline intervention.
Specifically, we will determine to what extent the site was
used, receive detailed feedback from users about their
experiences of the site, and identify any reported benefits and
costs to their mental health and wellbeing. This information
will be used to improve the site in accordance with user needs.
Wewill gain an estimate of the likely effect size of ERPonline on
a range of important outcomes, and explore potential mecha-
nisms of change, giving us a greater understanding of the
underlying processes of change, and consequently how the site
could be made more effective. We will be able to determine
rates of recruitment and retention, and identify what factors
could improve these rates. All of these data are required
to inform further development of the intervention, and the
design of a large scale definitive evaluation of clinical and cost
effectiveness. At this stage, it is not possible to state exactly
how the large scale definitive trial will differ from the
current study as the findings from this study are needed
to inform the design. For example, any barriers to using
the intervention, recruitment and retention of participants,telephone assessment, and completion of the online measures,
could lead to substantial modifications to the design of the
subsequent definitive trial. However, the following differences
are likely: (1) amodified intervention in light of feedback; (2) a
larger sample topower a clinical and cost effectiveness analysis,
informed by estimates of effect sizes from the data collected in
this study; and (3) an analysis of cost effectiveness using the
online version of the CSRI developed in this study.
There are several studies completed or underway to
develop and evaluate web-based interventions for Bipolar
Disorder. All differ in the content of the intervention, mode of
delivery and support, and design of evaluation. This study has
several key strengths. Firstly, the content of the intervention is
based on existing interventions which have already been
shown to be effective when delivered in face to face therapy.
When offered in routine clinical care as a structured face to face
intervention, a pilot trial suggested that ERP may increase time
to next mood episode, and improve functioning [19]. The
adaptation of the content and design of the online version of
ERP is an iterative process involving a multidisciplinary team
and extensive service user involvement. Secondly, this protocol
describes a rigorously controlled trial in which diagnosis of
Bipolar Disorder is confirmed using the SCID interview, an
independent trial unit will conduct the randomisation, all
outcome assessments are blind rated or self-report, and there is
detailed data collected to define current treatment in both
study arms. Thirdly, the broad recruitment strategy offers the
approach to a wide range of people who meet the criteria for
Bipolar Disorder, including thosewhomay not choose to access
routine mental health services.
This study protocol also highlights some limitations of the
design. Firstly, the intervention focuses on preventing relapse.
We recognise that for some individuals, this may not be their
most valued goal, and that amore recovery-focussed approach,
such as that described by Jones and colleagues [36], may be
more flexible and able to meet the range of individual goals.
However, the evidence-base for this approach is only just
beginning to emerge [45], and there are challenges in
conceiving how this can be adapted to an online environment.
Secondly, this design fails to answer important questions about
the role of support in online interventions. Due to resources
available, we are unable to offer either peer or clinical support
alongside the website. Users are encouraged to engage
supporters from existing social networks where appropriate,
and are given the chance to post questions on our Frequently
Asked Questions page. This has the advantage that if effective,
the site offers a more efficient way to deliver support that is
more likely to be adopted in routine clinical services. However,
previous research in this broad area suggests that self-
management interventions are likely to be more effective
when they are supported [54,55], that this may be because of
greater adherence and use of the site [14], and that peer and
therapist support are both potential options [56]. However,
evidence is mixed with some studies finding no significant
benefit of support [57], suggesting that more research is
needed into the role of support in this area. Finally, this study
does not have an active treatment control arm so it will not be
possible to estimate the impact on outcome relative to a
different kind of website.
ERPonline has the potential to offer an easy to access, freely
available online resource that can provide an evidence-based
108 F. Lobban et al. / Contemporary Clinical Trials 41 (2015) 100–109approach to reduce relapse in people diagnosed with Bipolar
Disorder. This protocol describes the development of the
intervention and the acceptability and feasibility of evaluating
it using a RCT design, providing essential information to inform
a large definitive clinical and cost effectiveness evaluation.3.1. Ethics and research governance approval
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